Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-023749)

Filing Details

Accession Number:: 0001209191-23-023749
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-07 15:18:03
Reporting Period:: 2023-04-06

Accepted Time:: 2023-04-07 15:18:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783183	Phathom Pharmaceuticals Inc.	PHAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363812	Molly Henderson	C/O Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham NJ 07932	Cfo And Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-04-06	3,439	$7.27	72,576	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	339	Indirect	by 401(k)

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.